PHARMA EURASIA 2026

PHARMA EURASIA 2026 positions Tashkent as a regional meeting point for pharmaceutical technology, innovation, and cross-border business development across the Eurasian pharma sector.

Pharmaceutical technology, innovation, and business scope

The event is described as covering the latest in pharmaceutical technology, innovation, and business opportunities within the pharma sector. No specific tracks, sessions, or speakers are listed in the available source material; the stated scope spans technology and commercial development broadly across the industry.

Which business-development and supply-chain teams should plan for Tashkent

For pharma operators looking to establish or expand presence in Central Asian and Eurasian markets, the event's stated focus on business opportunities and technology makes it a relevant point of contact. The Tashkent venue signals a regional orientation that may be of particular interest to teams evaluating emerging-market partnerships or distribution channels.

Registration is open via the event website; no deadline or pricing information is available in the current source material.